Advertisement

Time-dependent impairments in learning and memory in Streptozotocin-induced hyperglycemic rats

  • Ayaz Ahmed
  • Guirong Zeng
  • Dejiang Jiang
  • Haiying Lin
  • Mudassar Azhar
  • Ahsana Dar Farooq
  • Muhammad Iqbal Choudhary
  • Xinmin LiuEmail author
  • Qiong WangEmail author
Original Article
  • 22 Downloads

Abstract

The sedentary lifestyle is responsible for the high prevalence of diabetes which also impairs cognition including learning and memory. Various studies have highlighted the learning and memory impairments in rodent models but data regarding the timeline of their development and their correlation to biochemical parameters are scarce. So, the present study was designed to investigate the type of memory which is more susceptible to hyperglycemia and its correlation with biochemical parameters such as inflammatory cytokines, cAMP response element binding (CREB) and protein kinase B (Akt) activation. Hyperglycemia was induced using streptozotocin (STZ, 45 mg/kg i.p.) and confirmed by measuring fasting blood glucose levels after 1 week of STZ injection. Learning and memory deficits were evaluated using the Novel Object Recognition Test (NORT) and Morris water maze (MWM), and correlated with biochemical parameters (TNF-α, IL-1β, and dopamine) at 3, 6 and 9 weeks. STZ-injected rats after 3 weeks of injection demonstrated moderate hyperglycemia (blood glucose = 7.99 ± 0.62 mM) with intact learning and reference memory; however, their working memory was impaired in MWM. Severe hyperglycemia (blood glucose = 11.51 ± 0.69 mM) accompanied by impaired short, long, and working memory was evident after 6 weeks whereas learning was intact. After 9 weeks of STZ injection, hyperglycemia was more pronounced (13.69 ± 1.43 mM) and accompanied by a learning deficit in addition to short, long, and working memory impairments. The extent of hyperglycemia either in terms of duration or severity resulted in enhanced inflammation, down-regulation of the level of dopamine, protein expression of AKT and CREB, which possibly affected learning and memory negatively.

Keywords

Hyperglycemia Learning and memory Novel object recognition test Morris water maze Dopamine AKT CREB 

Notes

Acknowledgements

This work was supported by CAMS Initiatives for Innovation Medicine (2016-12 M-2-006), the National Key Research and Development Program of China (2016YFE0131800), the Joint Funds of the Southwest Medical University & Luzhou Municipal Government of China 2015LZCYD-S04 (7/15), Hunan Province Science and Technology Plan Projects of China (2015DK3010, the High - end Talents Recruitment Program (Chen Chen group) of Luzhou Municipal People’s Government. We would like to thank Dr. Radhakrishnan Rajan, College of Medicine, MBR University, Dubai, UAE, for his kind help to revise the manuscript. We would also like to thank the editor and reviewers of this manuscript whose critical reviews help us to make the draft better.

References

  1. (WHO), W. H. O. 2016. Global Reports on DiabeticsGoogle Scholar
  2. Alvarez EO, Beauquis J, Revsin Y, Banzan AM, Roig P, De Nicola AF, Saravia F (2009) Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 198:224–230CrossRefGoogle Scholar
  3. Ayoub, R. A. 2009. Effect of exercise on spatial learning and memory in male diabetic rats. Int J Diabetes & Metabolism (2009) 17:93–98 17:93–98Google Scholar
  4. Bach EC, Halmos KC, Smith BN (2015) Enhanced NMDA receptor-mediated modulation of excitatory neurotransmission in the dorsal vagal complex of streptozotocin-treated, chronically hyperglycemic mice. PLoS One 10:e0121022CrossRefGoogle Scholar
  5. Baddeley AD, Hitch G (1974) Working memory. In: Bower GH (ed) The psychology of learning and motivation: advances in research and theory, vol 8, pp 47–89Google Scholar
  6. Beauquis J, Homo-Delarche F, Giroix MH, Ehses J, Coulaud J, Roig P, Portha B, De Nicola AF, Saravia F (2010) Hippocampal neurovascular and hypothalamic-pituitary-adrenal axis alterations in spontaneously type 2 diabetic GK rats. Exp Neurol 222:125–134CrossRefGoogle Scholar
  7. Benedict C, Brooks SJ, Kullberg J, Burgos J, Kempton MJ, Nordenskjold R, Nylander R, Kilander L, Craft S, Larsson EM, Johansson L, Ahlstrom H, Lind L, Schioth HB (2012) Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35:488–494CrossRefGoogle Scholar
  8. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH (1998) Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800:125–135CrossRefGoogle Scholar
  9. Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, Ninomiya T, Ohara T, Peters R, Russ TC, Seshadri S, Strand BH, Walker R, Xu W, Huxley RR (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39:300–307Google Scholar
  10. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW (2008) Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 22:301–311CrossRefGoogle Scholar
  11. Chen HT, Ruan NY, Chen JC, Lin TY (2012) Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation. ASN Neuro 4:371–382CrossRefGoogle Scholar
  12. Chen Q, Mo R, Wu N, Zou X, Shi C, Gong J, Li J, Fang K, Wang D, Yang D, Wang K, Chen J (2017) Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats. Front Pharmacol 8:334CrossRefGoogle Scholar
  13. Choi BY, Kim IY, Kim JH, Lee BE, Lee SH, Kho AR, Sohn M, Suh SW (2017) Administration of Zinc plus Cyclo-(his-pro) increases hippocampal neurogenesis in rats during the early phase of Streptozotocin-induced diabetes. Int J Mol Sci 18Google Scholar
  14. Chu PC, Lin MT, Shian LR, Leu SY (1986) Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes 35:481–485CrossRefGoogle Scholar
  15. Culley DJ, Snayd M, Baxter MG, Xie Z, Lee IH, Rudolph J, Inouye SK, Marcantonio ER, Crosby G (2014) Systemic inflammation impairs attention and cognitive flexibility but not associative learning in aged rats: possible implications for delirium. Front Aging Neurosci 6:107CrossRefGoogle Scholar
  16. Dang H, Sun L, Liu X, Peng B, Wang Q, Jia W, Chen Y, Pan A, Xiao P (2009) Preventive action of Kai Xin san aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress. Exp Biol Med (Maywood) 234:785–793CrossRefGoogle Scholar
  17. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC (2011) Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim 45:131–140CrossRefGoogle Scholar
  18. Dong Y, Pu K, Duan W, Chen H, Chen L, Wang Y (2018) Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1beta-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons. BMC Neurosci 19(1):52CrossRefGoogle Scholar
  19. Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C (2003) Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 87:922–934CrossRefGoogle Scholar
  20. Edelmann E, Lessmann V (2018) Dopaminergic innervation and modulation of hippocampal networks. Cell Tissue Res 373:711–727CrossRefGoogle Scholar
  21. Ennaceur A (2010) One-trial object recognition in rats and mice: methodological and theoretical issues. Behav Brain Res 215:244–254CrossRefGoogle Scholar
  22. Ezzeldin E, Souror WA, El-Nahhas T, Soudi AN, Shahat AA (2014) Biochemical and neurotransmitters changes associated with tramadol in streptozotocin-induced diabetes in rats. Biomed Res Int 2014:238780CrossRefGoogle Scholar
  23. Feinkohl I, Price JF, Strachan MW, Frier BM (2015) The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther 7:46CrossRefGoogle Scholar
  24. Gajdosik A, Gajdosikova A, Stefek M, Navarova J, Hozova R (1999) Streptozotocin-induced experimental diabetes in male Wistar rats. Gen Physiol Biophys 18 Spec No:54–62Google Scholar
  25. Gao HL, Xu H, Xin N, Zheng W, Chi ZH, Wang ZY (2011) Disruption of the CaMKII/CREB signaling is associated with zinc deficiency-induced learning and memory impairments. Neurotox Res 19(4):584–591CrossRefGoogle Scholar
  26. Gardoni F, Kamal A, Bellone C, Biessels GJ, Ramakers GM, Cattabeni F, Gispent WH, Di Luca M (2002) Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats. J Neurochem 80:438–447CrossRefGoogle Scholar
  27. Gasbarri A, Sulli A, Innocenzi R, Pacitti C, Brioni JD (1996) Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience 74:1037–1044CrossRefGoogle Scholar
  28. Gutierrez A, Williams MT, Vorhees CV (2018) A single high dose of methamphetamine reduces monoamines and impairs egocentric and Allocentric learning and memory in adult male rats. Neurotox Res 33:671–680CrossRefGoogle Scholar
  29. Jayanarayanan S, Smijin S, Peeyush KT, Anju TR, Paulose CS (2013) NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chem Biol Interact 201:39–48CrossRefGoogle Scholar
  30. Jing XH, Chen SL, Shi H, Cai H, Jin ZG (2008) Electroacupuncture restores learning and memory impairment induced by both diabetes mellitus and cerebral ischemia in rats. Neurosci Lett 443:193–198CrossRefGoogle Scholar
  31. Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morre JT, Zuloaga DG, Weber S, Marzulla T, Mulford A, Button D, Lindner JR, Alkayed NJ, Stevens JF, Raber J (2016) Amelioration of metabolic syndrome-associated cognitive impairments in mice via a reduction in dietary fat content or infusion of non-diabetic plasma. EBioMedicine 3:26–42CrossRefGoogle Scholar
  32. Kamal A, Biessels GJ, Duis SE, Gispen WH (2000) Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 43:500–506CrossRefGoogle Scholar
  33. Kamal A, Ramakers GM, Gispen WH, Biessels GJ (2012) Effect of chronic intracerebroventricular insulin administration in rats on the peripheral glucose metabolism and synaptic plasticity of CA1 hippocampal neurons. Brain Res 1435:99–104CrossRefGoogle Scholar
  34. Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol 14:329–340CrossRefGoogle Scholar
  35. Kuhad A, Chopra K (2008) Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res 185:411–420CrossRefGoogle Scholar
  36. Lacosta S, Merali Z, Anisman H (1998) Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice. Psychopharmacology 137:351–361CrossRefGoogle Scholar
  37. Landeira BS, Santana T, Araujo JAM, Tabet EI, Tannous BA, Schroeder T, Costa MR (2016) Activity-independent effects of CREB on neuronal survival and differentiation during mouse cerebral cortex development. Cereb Cortex 28(2):538–548Google Scholar
  38. Langston RF, Stevenson CH, Wilson CL, Saunders I, Wood ER (2010) The role of hippocampal subregions in memory for stimulus associations. Behav Brain Res 215:275–291CrossRefGoogle Scholar
  39. Long AN, Dagogo-Jack S (2011) Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich) 13:244–251CrossRefGoogle Scholar
  40. Matsunaga Y, Negishi T, Hatakeyama A, Kawagoe Y, Sawano E, Tashiro T (2016) Impairment of synaptic development in the hippocampus of diabetic Goto-Kakizaki rats. Int J Dev Neurosci 53:58–67CrossRefGoogle Scholar
  41. Mayeda ER, Haan MN, Yaffe K, Kanaya AM, Neuhaus J (2015) Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans? Alzheimer Dis Assoc Disord 29:206–212CrossRefGoogle Scholar
  42. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47–60CrossRefGoogle Scholar
  43. Murray C, Sanderson DJ, Barkus C, Deacon RM, Rawlins JN, Bannerman DM, Cunningham C (2012) Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol Aging 33:603–616 e603CrossRefGoogle Scholar
  44. Noor A, Zahid S (2017) Alterations in adult hippocampal neurogenesis, aberrant protein s-nitrosylation, and associated spatial memory loss in streptozotocin-induced diabetes mellitus type 2 mice. Iran J Basic Med Sci 20:1159–1165Google Scholar
  45. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM (2010) Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem cohort study. Diabetes Care 33:1964–1969CrossRefGoogle Scholar
  46. Rask-Madsen C, King GL (2013) Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17:20–33CrossRefGoogle Scholar
  47. Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, Sano M, Leroith D, Johnson S, Preiss R, Koifman K, Hoffman H, Silverman JM, Beeri MS (2014) Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. PLoS One 9:e97384CrossRefGoogle Scholar
  48. Redondo MT, Beltran-Brotons JL, Reales JM, Ballesteros S (2016) Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults. Exp Gerontol 83:47–55CrossRefGoogle Scholar
  49. Revsin Y, Rekers NV, Louwe MC, Saravia FE, De Nicola AF, de Kloet ER, Oitzl MS (2009) Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 34:747–758CrossRefGoogle Scholar
  50. Rosa E, Fahnestock M (2015) CREB expression mediates amyloid beta-induced basal BDNF downregulation. Neurobiol Aging 36(8):2406–2413CrossRefGoogle Scholar
  51. Sadek KM, Lebda MA, Nasr SM, Shoukry M (2017) Spirulina platensis prevents hyperglycemia in rats by modulating gluconeogenesis and apoptosis via modification of oxidative stress and MAPK-pathways. Biomed Pharmacother 92:1085–1094CrossRefGoogle Scholar
  52. Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326–1333CrossRefGoogle Scholar
  53. Small DM (2017) Dopamine adaptations as a common pathway for neurocognitive impairment in diabetes and obesity: a neuropsychological perspective. Front Neurosci 11:134CrossRefGoogle Scholar
  54. Song C, Manku MS, Horrobin DF (2008) Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats. J Nutr 138:954–963CrossRefGoogle Scholar
  55. Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW (2006) Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci 26:10709–10716CrossRefGoogle Scholar
  56. Stranahan AM, Lee K, Mattson MP (2008) Central mechanisms of HPA axis regulation by voluntary exercise. NeuroMolecular Med 10:118–127CrossRefGoogle Scholar
  57. Stranahan AM, Arumugam TV, Lee K, Mattson MP (2010) Mineralocorticoid receptor activation restores medial perforant path LTP in diabetic rats. Synapse 64:528–532CrossRefGoogle Scholar
  58. Tian Z, Wang J, Xu M, Wang Y, Zhang M, Zhou Y (2016) Resveratrol improves cognitive impairment by regulating apoptosis and synaptic plasticity in Streptozotocin-induced diabetic rats. Cell Physiol Biochem 40:1670–1677CrossRefGoogle Scholar
  59. Tsao CW, Seshadri S, Beiser AS, Westwood AJ, CeCarli C, Au R, Himali JJ, Hamburg NM, Vita JA, Levy D, Larson MG, Benjamin EJ, Wolf PA, Vasan RS, Mitchell GF (2013) Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology 81:984–991CrossRefGoogle Scholar
  60. Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease. Mediat Inflamm 2015:105828CrossRefGoogle Scholar
  61. Wang XK, Sun T, Li YJ, Wang YH, Li YJ, Yang LD, Feng D, Zhao MG, Wu YM (2017) A novel thiazolidinediones ATZD2 rescues memory deficits in a rat model of type 2 diabetes through antioxidant and antiinflammation. Oncotarget 8:107409–107422Google Scholar
  62. Warburton EC, Barker GR, Brown MW (2013) Investigations into the involvement of NMDA mechanisms in recognition memory. Neuropharmacology 74:41–47CrossRefGoogle Scholar
  63. Wongchitrat P, Lansubsakul N, Kamsrijai U, Sae-Ung K, Mukda S, Govitrapong P (2016) Melatonin attenuates the high-fat diet and streptozotocin-induced reduction in rat hippocampal neurogenesis. Neurochem Int 100:97–109CrossRefGoogle Scholar
  64. Xu P, Wang K, Lu C, Dong L, Gao L, Yan M, Aibai S, Liu X (2016a) Protective effect of lavender oil on scopolamine induced cognitive deficits in mice and H2O2 induced cytotoxicity in PC12 cells. J Ethnopharmacol 193:408–415CrossRefGoogle Scholar
  65. Xu P, Xu SP, Wang KZ, Lu C, Zhang HX, Pan RL, Qi C, Yang YY, Li YH, Liu XM (2016b) Cognitive-enhancing effects of hydrolysate of polygalasaponin in SAMP8 mice. J Zhejiang Univ Sci B 17:503–514CrossRefGoogle Scholar
  66. Yossifoff M, Kisliouk T, Meiri N (2008) Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter. Eur J Neurosci 28(11):2267–2277CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ayaz Ahmed
    • 1
    • 2
    • 3
  • Guirong Zeng
    • 2
    • 4
  • Dejiang Jiang
    • 2
  • Haiying Lin
    • 1
  • Mudassar Azhar
    • 2
    • 3
  • Ahsana Dar Farooq
    • 5
  • Muhammad Iqbal Choudhary
    • 3
    • 6
  • Xinmin Liu
    • 1
    • 2
    • 4
    Email author
  • Qiong Wang
    • 1
    Email author
  1. 1.Affiliated TCM hospital/ Sino-Portugal TCM International Cooperation Center / Department of Physiology in School of Basic Medical SciencesSouthwest Medical UniversityLuzhouChina
  2. 2.Hunan Provincial Research Center for Safety Evaluation of DrugsChangshaChina
  3. 3.Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological SciencesUniversity of KarachiKarachiPakistan
  4. 4.Research Center for Pharmacology & Toxicology, Institute of Medicinal Plant Development (IMPLAD)Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  5. 5.Hamdard Al-Majeed College of Eastern MedicineHamdard UniversityKarachiPakistan
  6. 6.Department of Biochemistry, College of ScienceKing Abdulaziz UniversityJeddahSaudi Arabia

Personalised recommendations